Intensity Therapeutics receives Nasdaq non-compliance notice for stockholders' equity

INTENSITY THERAPEUTICS, INC.

Nasdaq notified company on May 19, 2025 of failure to meet minimum $2.5M stockholders' equity requirement.
Company has until July 3, 2025 to submit a plan to regain compliance.
If plan accepted, Nasdaq may grant up to 180-day extension from notice date.
Failure could lead to delisting of common stock (INTS); no immediate effect on listing.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.